Clostridioides
Overview[edit]
Clostridioides difficile, formerly known as Clostridium difficile, is a species of Gram-positive bacteria that is known to cause gastrointestinal infections, particularly in individuals who have been treated with antibiotics. It is an anaerobic bacterium that forms spores, which can survive in harsh environments and are resistant to many common disinfectants.
Pathogenesis[edit]
C. difficile is a major cause of antibiotic-associated diarrhea and can lead to more severe conditions such as pseudomembranous colitis. The bacterium produces two main toxins, toxin A and toxin B, which disrupt the normal function of the intestinal epithelium, leading to inflammation and damage.
Transmission[edit]
The spores of C. difficile are typically spread via the fecal-oral route. They can be found in healthcare settings, where they are a common cause of nosocomial infections. Proper hygiene and infection control measures are crucial in preventing the spread of this bacterium.
Diagnosis[edit]
Diagnosis of C. difficile infection is typically made by detecting the presence of its toxins in a stool sample. Polymerase chain reaction (PCR) tests and enzyme immunoassays are commonly used methods.
Treatment[edit]
The primary treatment for C. difficile infection involves the use of specific antibiotics such as metronidazole or vancomycin. In severe cases, fidaxomicin may be used. In recurrent cases, fecal microbiota transplantation has shown effectiveness in restoring the normal gut flora.
Prevention[edit]
Preventive measures include the judicious use of antibiotics, proper hand hygiene, and thorough cleaning of healthcare environments. The use of probiotics is also being explored as a preventive strategy.
